Is MDWD or NAGE more undervalued in 2026?

CirclFi compares MediWound Ltd. (MDWD) and Niagen Bioscience, Inc. (NAGE) using 13 institutional-grade valuation models. MDWD has a Quality of Company score of 1.8/10 while NAGE scores 8.9/10.

Which is a better buy — MDWD or NAGE?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do MDWD and NAGE valuations compare?

MDWD at $14.33 and NAGE at $3.86 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

MDWD vs NAGE Valuation Comparison 2026 — Intrinsic Value Analysis

MDWD

Medicinal Chemicals & Botanical Products

MediWound Ltd.

Quality

1.8

out of 10

Value Trap

SAFE

Price

$14.33

Last close

Models

11/13

Active

NAGE

Medicinal Chemicals & Botanical Products

Niagen Bioscience, Inc.

Quality

8.9

out of 10

Value Trap

SAFE

Price

$3.86

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	MDWD Fair Value	MDWD Upside	NAGE Fair Value	NAGE Upside
Bayesian DCF	Intrinsic	$3.34	-76.7%	$3.66	-5.3%
Earnings Power Value	Intrinsic	$1.08	-93.5%	$2.53	-34.4%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for MDWD vs NAGE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MDWD vs NAGE — Which Stock Is More Undervalued?

NAGE scores higher with a 8.9/10 quality rating vs MDWD's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing MediWound Ltd. (MDWD) and Niagen Bioscience, Inc. (NAGE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MDWD currently trades at $14.33 with a QOC of 1.8/10, while NAGE trades at $3.86 with a QOC of 8.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).